System Transmission

Top Signal

100#1 JOB

Activity

2164Ripe

+918 today

System

Livenow

Terminal Asset View

stockNASDAQ

BCDA

$1.26-0.79%

BioCardia Inc

Ripening

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

52Ripening

Live Analysis Active

Company Mission

BioCardia develops cell-based therapies for treating heart conditions like heart failure. The company creates treatments that use a patient's own cells to help repair damaged heart tissue. Doctors and hospitals use these therapies in clinical trials to test their effectiveness. BioCardia makes money by conducting these trials and hopes to eventually sell approved treatments to healthcare providers.

BCD

Industry Context

The biotech industry focuses on developing medical treatments using biological processes. Companies in this space often work on innovative therapies for serious diseases, with success depending on clinical trial results and regulatory approvals. BioCardia operates in the regenerative medicine segment, which aims to repair damaged tissues using cells or biological materials.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

77Matrix

Market Momentum

52.1— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-0.79%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BCDA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:45 PM UTC

As-of 03-14-2026 17:30 UTC

Develops cell therapies for heart disease and makes money by charging hospitals for treatments and licensing its technology to other companies.

Monthly chart shows base formation near recent lows, suggesting a strong foundation for potential moves showing consolidation pattern.

Biotech sector showing interest in regenerative medicine, which could benefit companies developing advanced cell therapies.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...